Press Releases Patient Six Cancer-Free Eighteen Months After Single Anti-Cancer TreatmentSeptember 30, 2019Theralase Grants Stock OptionsSeptember 16, 2019Theralase Announces First Patient Treated in Phase II Non-Muscle Invasive Bladder Cancer Clinical StudySeptember 04, 2019Theralase Releases Second Quarter 2019 Financial Results and Company UpdateAugust 29, 2019THERALASE ANNOUNCES CLOSING OF PROSPECTUS OFFERING FOR GROSS PROCEEDS OF $17,250,000August 22, 2019Patient Five Cancer-Free Eighteen Months After Single Anti-Cancer TreatmentJuly 31, 2019McGill University Health Centre Newest Clinical Study Site for Phase II Non-Muscle Invasive Bladder Cancer Clinical StudyJuly 30, 2019Theralase Enrolls First Patient into Phase II Non-Muscle Invasive Bladder Cancer Clinical StudyJuly 29, 2019Theralase Signs Agreement with Urology Organization to Provide US Clinical Study Sites for its Phase II Non Muscle Invasive Bladder Cancer Clinical StudyJuly 24, 2019Theralase Receives Notice of Acceptance for Multiwavelength Photo Dynamic Therapy from Russian Patent OfficeJuly 16, 2019Theralase Releases 2019 Annual General Meeting Video PresentationsJune 28, 2019Regulatory Updates from Health Canada and US FDAJune 27, 2019Theralase Files Prospectus for Offering of UnitsJune 26, 2019Health Canada Approves Amended Clinical Trial ApplicationJune 26, 2019Theralase Brain Cancer Pre-Clinical Research Accepted for PublicationJune 25, 2019Theralase Releases Amended and Restated 1Q2019 Financial StatementsJune 18, 2019Theralase® Releases 1Q2019 Financial StatementsMay 30, 2019Theralase® Granted Notice of Acceptance for PhotoDynamic Compounds by Chinese Patent OfficeMay 20, 2019Theralase’s 5th Annual Medical and Scientific Advisory Board Meeting Advances Phase II Non-Muscle Invasive Bladder Cancer Clinical StudyMay 13, 2019Chinese Patent Office Issues Notice of Acceptance for Multiwavelength PhotoDynamic TherapyMay 07, 2019« Previous1234…11Next » We exhibit at .. Discover our Therapeutic Lasers Read our latest blog articles .. Developing a Potential Cure for Bladder Cancer Theralase – Participating in Bladder Cancer Walk 2019 Canadian Clinical Stage Biopharmaceutical Company Advances New Cancer Treatment Active Rehabilitation – How Much is Too Much? Speeding up Athletes’ Recovery ✴ Guest blog post by Dr. JEFFREY TUCKER, D.C. Theralase Laser Technology – The Magic Lamp? ✴ Guest blog post by Dr. JAMES W. GREGG, D.C. Treating Sports-Related Ankle Sprains Natural, Drug-free Pain Management ✴ Guest blog post by Dr. JEFFREY TUCKER, D.C. Are Soccer Moms Now the Candidates Most Likely to Succumb to Drug Addiction? Everything You Need To Know About Class 3 vs. Class 4 123
